Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products

A multiple-award, indefinite-delivery/indefinite-quantity contract has been awarded under Solicitation #75N95025R00005 for Chemistry, Manufacturing and Controls and Related Services for the Development of Drug Products, with an ordering period running from July 1, 2026, through July 31, 2031. The contract is administered by the National Institutes of Health, National Institute of Allergy and Infectious Diseases, under the Department of Health and Human Services, with performance primarily centered in Lexington, Kentucky, and the primary point of contact located in Bethesda, Maryland. Task orders issued under this contract are expected to be predominantly cost-reimbursement or term/completion type, due to the highly dynamic, science-responsive, and results-driven nature of the work, which makes precise cost estimation and fixed pricing impractical. The government has determined that fixed-price arrangements would impose undue risk and limit necessary flexibility to adapt to evolving scientific requirements, although fixed-price task orders remain possible where feasible and appropriate. The contractor is eligible to compete for task orders under Technical Area 1, and no specific set-aside is applied to this contract.